Green Thumb Industries Inc. (OTCMKTS:GTBIF – Free Report) – Stock analysts at Cormark reduced their FY2024 earnings per share estimates for shares of Green Thumb Industries in a report issued on Monday, November 11th. Cormark analyst J. Pytlak now anticipates that the company will post earnings of $0.33 per share for the year, down from their previous estimate of $0.38. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Cormark also issued estimates for Green Thumb Industries’ FY2025 earnings at $0.40 EPS.
Several other research analysts have also weighed in on GTBIF. Roth Capital raised Green Thumb Industries to a “strong-buy” rating in a research report on Sunday. Ventum Cap Mkts raised Green Thumb Industries to a “strong-buy” rating in a research report on Tuesday, August 6th. Finally, Craig Hallum raised Green Thumb Industries to a “strong-buy” rating in a research report on Monday, September 16th. Three equities research analysts have rated the stock with a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Strong Buy” and a consensus price target of $16.50.
Green Thumb Industries Stock Performance
Shares of OTCMKTS:GTBIF opened at $9.70 on Wednesday. The business’s fifty day moving average price is $10.24 and its two-hundred day moving average price is $11.08. The stock has a market cap of $2.05 billion, a PE ratio of 35.93 and a beta of 1.40. Green Thumb Industries has a one year low of $7.50 and a one year high of $16.33.
Green Thumb Industries (OTCMKTS:GTBIF – Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02). Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%. The business had revenue of $286.87 million for the quarter, compared to analyst estimates of $283.96 million.
About Green Thumb Industries
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Featured Stories
- Five stocks we like better than Green Thumb Industries
- Golden Cross Stocks: Pattern, Examples and Charts
- Rocket Lab is the Right Stock for the Right Time
- Best Stocks Under $5.00
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.